her2 positive

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Malignancy, Safety and Tolerability, Pharmacokinetics Trial in Worldwide (AZD5363)

Active, not recruiting
  • Advanced Solid Malignancy
  • +13 more
  • Los Angeles, California
  • +33 more
Dec 22, 2022

Breast Cancer, HER2 Positive Trial in Netherlands (PTC+Pertuzumab, FEC-T+Pertuzumab)

Active, not recruiting
  • Breast Cancer
  • HER2 Positive
  • Alkmaar, Netherlands
  • +32 more
Oct 11, 2022

Breast Cancer, Metastatic Breast Cancer, MBC Trial in United States (Lucitanib)

Terminated
  • Breast Cancer
  • +7 more
  • Sedona, Arizona
  • +32 more
Jun 20, 2020

Breast Cancer, HER2 Positive, Combination Chemo Trial in Chengdu (Pyrotinib Maleate Tablets, Albumin Paclitaxel, Trastuzumab)

Unknown status
  • Breast Cancer
  • +2 more
  • Pyrotinib Maleate Tablets
  • +2 more
  • Chengdu, Chengdu, Sichuan, China, China
    West China Hospital, Sichuan University
Nov 1, 2019

Metastatic Breast Cancer, HER2 Positive, First or Second Line Therapy Trial in Germany (Lapatinib and Capecitabine and

Terminated
  • Metastatic Breast Cancer
  • +3 more
  • Lapatinib and Capecitabine and Vinorelbine
  • Ravensburg, Baden-Württemberg, Germany
  • +10 more
Nov 20, 2014

Metastatic Breast Cancer, Brain Metastases, HER2 Positive Trial in Brussels (lapatinib and temozolomide)

Completed
  • Metastatic Breast Cancer
  • +2 more
  • lapatinib and temozolomide
  • Brussels, Belgium
    Jules Bordet Institute
Sep 18, 2012

Breast Cancer, HER2 Positive Trial in Netherlands (paclitaxel, trastuzumab and carboplatin)

Completed
  • Breast Cancer
  • HER2 Positive
  • paclitaxel, trastuzumab and carboplatin
  • Alkmaar, Netherlands
  • +8 more
May 10, 2012